Target Name: CD40LG
NCBI ID: G959
Review Report on CD40LG Target / Biomarker Content of Review Report on CD40LG Target / Biomarker
CD40LG
Other Name(s): IMD3 | tumor necrosis factor (ligand) superfamily member 5 | CD40-L | sCD40L | hCD40L | CD40L_HUMAN | CD154 | T-BAM | CD40 antigen ligand | Tumor necrosis factor ligand superfamily member 5 | IGM | gp39 | CD40 ligand, soluble form | CD40L | TRAP | TNF-related activation protein | TNFSF5 | CD40 ligand, membrane form | sCD40L_(HUMAN) | HIGM1 | T-cell antigen Gp39 | Tumor necrosis factor (ligand) superfamily member 5 | T-B cell-activating molecule | CD40 ligand

CD40LG: A Promising Drug Target and Biomarker for Chronic Obstructive Pulmonary Disease

Abstract:

Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide, characterized by progressive lung airflow obstruction and chronic inflammation. The current treatment options for COPD are limited, and there is a growing need for new, more effective therapies to treat this debilitating disease. CD40LG, a protein that is expressed in high levels in the lungs of individuals with COPD, has been identified as a potential drug target and biomarker for COPD. This article will discuss the current state of research on CD40LG, its potential as a drug target and biomarker, and its potential impact on the treatment of COPD.

Introduction:

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that is characterized by airflow obstruction and chronic inflammation. It is a leading cause of morbidity and mortality worldwide, and its number is expected to reach 27 million by 2030. The current treatment options for COPD are limited and have not been able to fully alleviate the symptoms of this debilitating disease.

CD40LG: A Potential Drug Target and Biomarker

CD40LG is a protein that is expressed in high levels in the lungs of individuals with COPD. It is a type of transmembrane protein that is involved in the regulation of cell signaling pathways, including the T cell signaling pathway. High levels of CD40LG have been observed in individuals with COPD, and have been associated with increased severity of disease and reduced survival rates.

Recent studies have suggested that CD40LG may be a potential drug target for COPD. By targeting CD40LG, researchers have found that they can improve lung function and reduce inflammation in individuals with COPD. In addition, studies have shown that targeting CD40LG may be a more effective and less invasive way of treating COPD than traditional COPD treatments, such as bronchodilators.

CD40LG as a Biomarker:

In addition to its potential as a drug target, CD40LG has also been identified as a potential biomarker for COPD. The detection and quantification of CD40LG has been shown to be reliable and sensitive, making it an attractive tool for the study of COPD biomarkers. Several studies have shown that CD40LG levels are elevated in individuals with COPD, and that levels are correlated with severity of disease and survival rates. These findings suggest that CD40LG may be a useful biomarker for the diagnosis and monitoring of COPD.

CD40LG as a Potential Drug Target:

CD40LG has been shown to be involved in the regulation of cell signaling pathways, including the T cell signaling pathway. This suggests that it may be a potential target for the development of new COPD treatments. Researchers have found that by blocking the activity of CD40LG, they can improve lung function and reduce inflammation in individuals with COPD. In addition, studies have shown that targeting CD40LG may be more effective and less invasive than traditional COPD treatments, such as bronchodilators.

Conclusion:

CD40LG is a protein that is expressed in high levels in the lungs of individuals with COPD and has been identified as a potential drug target and biomarker for COPD. Its potential as a drug target and biomarker makes it an attractive tool for the development of new COPD treatments. Further research is needed to fully understand the effects of targeting CD40LG in individuals with COPD.

Protein Name: CD40 Ligand

Functions: Cytokine that acts as a ligand to CD40/TNFRSF5 (PubMed:1280226, PubMed:31331973). Costimulates T-cell proliferation and cytokine production (PubMed:8617933). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed:8617933). Induces the activation of NF-kappa-B (PubMed:15067037, PubMed:31331973). Induces the activation of kinases MAPK8 and PAK2 in T-cells (PubMed:15067037). Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed:15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity)

The "CD40LG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD40LG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18